{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:26:59Z","timestamp":1775802419358,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Mitochondrial diseases are a group of disorders in which mutations in mitochondrial DNA or nuclear DNA lead to dysfunctional oxidative phosphorylation of cells, with mutations in mitochondrial DNA being the most common cause of mitochondrial disease, and mutations in nuclear genes being rarely reported. The echocardiographic findings of mitochondrial diseases with nuclear gene mutations in children\u2019s hearts are even rarer. Even more valuable is that we followed up the patient for 4 years and dynamically observed the cardiac echocardiographic manifestations of mitochondrial disease. Provide ideas for the clinical diagnosis and prognosis of mitochondrial diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The patient was seen in the pediatric outpatient clinic for poor strength and mental retardation. echocardiography: mild left ventricular (LV) enlargement and LV wall thickening. Nuclear genetic testing: uanosine triphosphate binding protein 3 (GTPBP3) gene mutation. Diagnosis of mitochondrial disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Mitochondrial disease with GTPBP3 gene mutations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After receiving drug treatment, the patient exhibited a reduction in lactate levels, an enhanced physical condition compared to prior assessments, and demonstrated average intellectual development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons subsections:<\/jats:title>\n            <jats:p>For echocardiographic indications of LV wall thickening and LV enlargement, one needs to be alert to the possibility of hereditary cardiomyopathy, especially in children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037847","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T18:02:42Z","timestamp":1714759362000},"page":"e37847","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Echocardiographic manifestations of mitochondrial disease with GTPBP3 gene mutations: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Qiaoli","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Cardiac Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Cardiac Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-3798","authenticated-orcid":false,"given":"Hongning","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiac Ultrasound, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"385","article-title":"Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings.","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatrics"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","article-title":"Mitochondrial Cardiomyopathies.","volume":"3","author":"El-Hattab","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/nar\/gkab104","article-title":"The human tRNA taurine modification enzyme GTPBP3 is an active GTPase linked to mitochondrial diseases.","volume":"49","author":"Peng","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/genes14030552","article-title":"Pathogenicity Analysis of a Novel Variant in GTPBP3 causing mitochondrial disease and systematic literature review.","volume":"14","author":"Zhang","year":"2023","journal-title":"Genes (Basel)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"611226","DOI":"10.3389\/fgene.2021.611226","article-title":"Novel Mutations in the GTPBP3 Gene for mitochondrial disease and characteristics of related phenotypic spectrum: the first three cases From China.","volume":"12","author":"Yan","year":"2021","journal-title":"Front Genet"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehv306","article-title":"Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults.","volume":"37","author":"Ng","year":"2016","journal-title":"Eur Heart J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0960-8966(93)90116-2","article-title":"Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion.","volume":"3","author":"Tranchant","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome.","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J Rare Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:05:49Z","timestamp":1746320749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":10,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037847","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]}}}